tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Cumberland Pharmaceuticals Inc

CPIX
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
7.320USD
+0.130+1.81%
์ข…๊ฐ€ย 09-18 16:00๏ผˆET๏ผ‰
109.83M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

CPIX ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Cumberland Pharmaceuticals Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
109.83M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-14.81
์ฃผ๋‹น์ˆœ์ด์ต
-0.49
์ˆ˜์ต
44.52M
์ˆœ์ด์ต
-6.48M
ROE
-29.36%
ROA
-10.29%

Cumberland Pharmaceuticals Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
Aug 7, 2026
EPS / ์˜ˆ์ƒ
--/--
์ˆ˜์ต / ์˜ˆ์ƒ
--/--

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-476.53%-0.29
-361.37%-0.22
28.82%-0.10
-18.07%-0.13
35.62%-0.05
160.94%0.08
69.34%-0.14
-49.52%-0.11
-226.90%-0.08
-1131.76%-0.14
-162.12%-0.44
---0.07
--0.06
--0.01
---0.17
----
----
----
----
----
์ˆ˜์ต
-98.46%166.46K
-22.04%9.13M
31.08%13.68M
-8.73%8.29M
10.04%10.84M
37.84%11.71M
11.57%10.44M
-9.92%9.09M
-9.55%9.85M
-7.88%8.50M
2.51%9.35M
-11.63%10.09M
5.73%10.89M
-17.45%9.22M
9.66%9.12M
41.38%11.41M
13.73%10.30M
6.05%11.18M
-18.92%8.32M
-12.74%8.07M
์ˆœ์ด์ต
-477.31%-4.28M
-361.69%-3.29M
25.85%-1.41M
-25.69%-1.94M
31.77%-740.74K
164.59%1.26M
69.75%-1.90M
-47.15%-1.54M
-224.47%-1.09M
-1112.71%-1.95M
-157.89%-6.29M
-156.78%-1.05M
165.30%872.20K
113.87%192.18K
36.57%-2.44M
61.28%-408.64K
-208.71%-1.34M
-930.35%-1.39M
-335.37%-3.85M
-119.06%-1.06M
์ˆœ์ด์ต๋ฅ 
-27388.76%-1864.84%
-422.79%-34.40%
42.68%-10.44%
-38.95%-23.50%
39.40%-6.78%
147.60%10.66%
72.95%-18.22%
-60.47%-16.92%
-241.40%-11.20%
-1298.72%-22.39%
-149.92%-67.38%
---10.54%
--7.92%
--1.87%
---26.96%
----
----
----
----
----
์ด ์ด์ต๋ฅ 
38.59%100.00%
-17.79%65.14%
13.61%76.21%
3.17%75.90%
0.97%72.15%
15.87%79.25%
-5.34%67.07%
3.85%73.57%
-5.22%71.46%
-6.46%68.39%
37.12%70.86%
--70.84%
--75.40%
--73.11%
--51.68%
----
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
-100.00%0.00%
-1.49%7.38%
-66.25%6.82%
-62.07%7.95%
-62.34%7.72%
-62.02%7.49%
29.28%20.21%
42.37%20.97%
39.31%20.49%
9.85%19.73%
-10.33%15.63%
--14.73%
--14.71%
--17.96%
--17.43%
----
----
----
----
----
์ˆ˜์ต
-98.46%166.46K
-22.04%9.13M
31.08%13.68M
-8.73%8.29M
10.04%10.84M
37.84%11.71M
11.57%10.44M
-9.92%9.09M
-9.55%9.85M
-7.88%8.50M
2.51%9.35M
-11.63%10.09M
5.73%10.89M
-17.45%9.22M
9.66%9.12M
41.38%11.41M
13.73%10.30M
6.05%11.18M
-18.92%8.32M
-12.74%8.07M
์˜์—… ์ด์ต
-322.82%-3.16M
-342.22%-3.13M
25.56%-1.37M
-15.98%-1.97M
27.20%-747.48K
169.12%1.29M
35.03%-1.84M
9.22%-1.69M
-4591.40%-1.03M
-22.04%-1.87M
20.75%-2.84M
-464.99%-1.87M
101.58%22.86K
-121.34%-1.53M
-9.95%-3.58M
132.71%511.41K
-17.06%-1.45M
-208.51%-692.00K
-110.49%-3.25M
-29.35%-1.56M
์ˆœ์ด์ต
-477.31%-4.28M
-361.69%-3.29M
25.85%-1.41M
-25.69%-1.94M
31.77%-740.74K
164.59%1.26M
69.75%-1.90M
-47.15%-1.54M
-224.47%-1.09M
-1112.71%-1.95M
-157.89%-6.29M
-156.78%-1.05M
165.30%872.20K
113.87%192.18K
36.57%-2.44M
61.28%-408.64K
-208.71%-1.34M
-930.35%-1.39M
-335.37%-3.85M
-119.06%-1.06M
์œ ๋™์ž์‚ฐ
7.81%33.64M
2.86%32.79M
1.67%37.06M
-15.03%29.94M
-12.30%31.21M
-11.96%31.88M
2.07%36.45M
-15.64%35.24M
-18.53%35.58M
-17.36%36.21M
-22.14%35.71M
-15.03%41.77M
-0.17%43.67M
-3.38%43.81M
0.40%45.87M
4.12%49.16M
-6.28%43.75M
-8.18%45.34M
-8.57%45.69M
-3.43%47.22M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
46.81%35.19M
35.14%34.49M
16.20%36.74M
-21.80%24.31M
-3.17%23.97M
-3.43%25.52M
13.01%31.62M
13.76%31.09M
-8.17%24.76M
2.79%26.43M
-2.09%27.98M
7.99%27.33M
11.16%26.96M
4.68%25.71M
48.24%28.58M
41.02%25.31M
30.06%24.25M
7.48%24.56M
-24.89%19.28M
-25.03%17.95M
์ด ์ž์‚ฐ
-7.40%62.88M
1.51%71.00M
1.64%76.82M
-14.14%65.90M
-13.52%67.91M
-14.20%69.94M
-7.57%75.58M
-12.54%76.75M
-12.15%78.52M
-8.90%81.51M
-12.00%81.78M
-3.33%87.75M
-3.40%89.38M
-7.48%89.47M
10.02%92.93M
3.66%90.78M
4.13%92.52M
3.59%96.70M
-12.44%84.46M
-8.79%87.57M
๋ถ€์ฑ„ ์ด๊ณ„
13.78%45.77M
19.47%49.69M
-1.43%52.28M
-23.30%40.10M
-23.36%40.23M
-23.43%41.60M
0.99%53.04M
0.35%52.28M
-0.10%52.49M
1.68%54.32M
-7.79%52.52M
-0.36%52.10M
-1.45%52.54M
-4.44%53.42M
36.06%56.95M
27.76%52.29M
29.90%53.31M
20.30%55.90M
-15.59%41.86M
-15.03%40.92M
์ž๋ณธ ์ด๊ณ„
-38.20%17.11M
-24.83%21.30M
8.86%24.54M
5.44%25.80M
6.33%27.68M
4.23%28.34M
-22.95%22.55M
-31.37%24.47M
-29.33%26.03M
-24.58%27.19M
-18.66%29.26M
-7.37%35.66M
-6.04%36.84M
-11.63%36.05M
-15.56%35.97M
-17.48%38.49M
-18.00%39.20M
-12.98%40.79M
-9.11%42.60M
-2.50%46.65M
์ˆœ์˜์—…์ด์ต
-560.36%-3.88M
-90.07%387.02K
-99.84%3.02K
-60.64%187.18K
198.61%843.80K
282.46%3.90M
83.12%1.90M
-61.55%475.50K
-116.34%-855.66K
-50.66%-2.14M
-71.41%1.04M
-53.08%1.24M
124.64%5.24M
-842.34%-1.42M
149.80%3.64M
540.11%2.64M
5.91%2.33M
-111.67%-150.50K
392.30%1.46M
-1059.30%-598.79K
์ˆœํˆฌ์ž
-723.01%-1.78M
95.02%-61.17K
-11363.83%-3.07M
-464.29%-690.84K
710.77%285.86K
-2010.79%-1.23M
-110.29%-26.81K
299.47%189.64K
51.65%-46.80K
66.65%-58.19K
140.68%260.64K
-113.96%-95.07K
43.91%-96.81K
98.71%-174.45K
-2291.39%-640.77K
728.95%680.80K
-255.76%-172.59K
-4153.90%-13.54M
91.52%-26.80K
83.81%-108.24K
์ˆœ์žฌ๋ฌดํ™œ๋™
-3472.46%-5.39M
86.19%-763.30K
50.54%-681.74K
27.93%-386.88K
51.29%-150.80K
-328.19%-5.53M
7.31%-1.38M
39.18%-536.84K
90.55%-309.57K
236.12%2.42M
46.52%-1.49M
55.67%-882.60K
-171.12%-3.28M
-145.41%-1.78M
-278.19%-2.78M
-619.86%-1.99M
36.52%-1.21M
401.86%3.92M
69.75%-735.30K
141.84%383.02K

์ˆ˜์ต๎˜

์‚ฌ์—…๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ง€์—ญ๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Cumberland Pharmaceuticals Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cumberland Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 44.52M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 37.87M์ž…๋‹ˆ๋‹ค.

Cumberland Pharmaceuticals Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cumberland Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 37.06M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 1.67์ž…๋‹ˆ๋‹ค.

Cumberland Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cumberland Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Cumberland Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ 76.82M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 1.64์ž…๋‹ˆ๋‹ค.

Cumberland Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cumberland Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Cumberland Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” 52.28M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -1.43์ž…๋‹ˆ๋‹ค.

Cumberland Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cumberland Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Cumberland Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ 24.54M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 8.86์ž…๋‹ˆ๋‹ค.

Cumberland Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cumberland Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Cumberland Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -2.79M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 56.59์ž…๋‹ˆ๋‹ค.

Cumberland Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cumberland Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Cumberland Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” -4.71M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -8236.82์ž…๋‹ˆ๋‹ค.

Cumberland Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cumberland Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Cumberland Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ -6.75M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -3525.79์ž…๋‹ˆ๋‹ค.

Cumberland Pharmaceuticals Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cumberland Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -0.19์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 58.57์ž…๋‹ˆ๋‹ค.

Cumberland Pharmaceuticals Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cumberland Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -2.84M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 56.23์ž…๋‹ˆ๋‹ค.

Cumberland Pharmaceuticals Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cumberland Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -6.43์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 62.19์ž…๋‹ˆ๋‹ค.

Cumberland Pharmaceuticals Inc์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cumberland Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 75.71์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 8.69์ž…๋‹ˆ๋‹ค.

Cumberland Pharmaceuticals Inc์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cumberland Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 6.82์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -66.25์ž…๋‹ˆ๋‹ค.

Cumberland Pharmaceuticals Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cumberland Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -11.88์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 51.90์ž…๋‹ˆ๋‹ค.

Cumberland Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cumberland Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -3.76์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 54.10์ž…๋‹ˆ๋‹ค.

Cumberland Pharmaceuticals Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cumberland Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -2.79M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 56.59์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ